- Home
- FNLC vs ANGO Comparison
FNLC vs ANGO Comparison
Compare FNLC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNLC | ANGO |
|---|---|---|
| Founded | 1864 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.2M | 420.2M |
| IPO Year | 1995 | 2004 |
Fundamental Metrics
Financial Performance| Metric | FNLC | ANGO |
|---|---|---|
| Price | $35.03 | $15.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 18.7K | ★ 326.2K |
| Earning Date | 04-22-2026 | 04-02-2026 |
| Dividend Yield | ★ 5.19% | N/A |
| EPS Growth | ★ 26.34 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.51 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | $21.21 | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $24.13 | $9.39 |
| 52 Week High | $36.30 | $16.29 |
Technical Indicators
Market Signals| Indicator | FNLC | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 53.32 | 50.60 |
| Support Level | $34.72 | $10.56 |
| Resistance Level | $36.08 | $16.20 |
| Average True Range (ATR) | 0.76 | 0.46 |
| MACD | -0.09 | -0.12 |
| Stochastic Oscillator | 53.95 | 20.80 |
Price Performance
Historical ComparisonAbout FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services, including deposit accounts and consumer, commercial, and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.